Literature DB >> 6629323

Conversion of micronodular cirrhosis into macronodular cirrhosis.

L Fauerholdt, P Schlichting, E Christensen, H Poulsen, N Tygstrup, E Juhl.   

Abstract

The conversion from micro- to macronodular cirrhosis is claimed to be a general phenomenon. In this study, the conversion was quantitated by means of liver needle follow-up biopsies and autopsy in 156 patients followed in a controlled clinical trial of prednisone treatment in cirrhosis. In the initial biopsy, 75 patients were classified as micronodular cirrhosis, and of them, 68 had macronodular cirrhosis at autopsy indicating a conversion ratio of about 0.9 in 10 years. This may overestimate the true conversion ratio slightly since conversion in many cases only was demonstrated at autopsy where the diagnosis of macronodular cirrhosis is made with greater certainty than from a needle biopsy. The median time interval between the diagnosis of micro- and macronodular cirrhosis was 2.25 years which is a maximum estimate of the conversion time due to irregular spacing between biopsies (or biopsy and autopsy). No significant difference was found between the conversion time in females and males. The conversion was faster in patients not drinking alcohol compared to patients drinking alcohol, but the difference was not significant. Prednisone treatment tended to accelerate the conversion, but not significantly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629323     DOI: 10.1002/hep.1840030607

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Pathology for the HPB Surgeon.

Authors:  Chandralekha Tampi
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

3.  Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence.

Authors:  C O Bellamy; A M DiMartini; K Ruppert; A Jain; F Dodson; M Torbenson; T E Starzl; J J Fung; A J Demetris
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

4.  The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.

Authors:  Luis Servin-Abad; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-11

5.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 6.  Structural and functional aspects of regeneration of human liver.

Authors:  F Schaffner
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 7.  Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Authors:  Prodromos Hytiroglou; Neil D Theise
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

Review 8.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  The Assessment of the Quality of Life in Children with Chronic Liver Disease.

Authors:  Meliha Demiral; Tanju Başarır Özkan; Taner Özgür; Bige Özkan; Gülin Erdemir Eren; Derya Altay
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

10.  The identification of liver cirrhosis with modified LBP grayscaling and Otsu binarization.

Authors:  Karan Aggarwal; Manjit Singh Bhamrah; Hardeep Singh Ryait
Journal:  Springerplus       Date:  2016-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.